Yes, an interesting turn of phrase.
It would appear to me that means that EITHER outfit being successful results in a consultancy payment to both participants.
Perhaps it is the payment to the one that did not succeed while the other one has been successful.
If that is the case I would be looking forward to an announcement early Monday morning.
Non exclusivity also indicates there could be two agreements for differing parts of what is involved here.
You could have a partner coming aboard for Melanoma metastasis and another partner for Glioblastoma.
I cant for the life of me see any advantage in allowing of any hair related MK patents to be handed over
They will need these for ongoing product development.
Needs clarification from the company though, I agree
Ann: Appendix 2A, page-11
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1197315 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 59888 | 2 |
View Market Depth
| Last trade - 16.12pm 19/08/2024 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable